- Home
- GRND vs ALKS Comparison
GRND vs ALKS Comparison
Compare GRND & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRND
- ALKS
- Stock Information
- Founded
- GRND 2009
- ALKS 1987
- Country
- GRND United States
- ALKS Ireland
- Employees
- GRND N/A
- ALKS N/A
- Industry
- GRND Computer Software: Prepackaged Software
- ALKS Biotechnology: Pharmaceutical Preparations
- Sector
- GRND Technology
- ALKS Health Care
- Exchange
- GRND Nasdaq
- ALKS Nasdaq
- Market Cap
- GRND 4.6B
- ALKS 4.8B
- IPO Year
- GRND N/A
- ALKS 1991
- Fundamental
- Price
- GRND $23.02
- ALKS $29.83
- Analyst Decision
- GRND Strong Buy
- ALKS Buy
- Analyst Count
- GRND 5
- ALKS 13
- Target Price
- GRND $22.80
- ALKS $38.85
- AVG Volume (30 Days)
- GRND 1.7M
- ALKS 1.5M
- Earning Date
- GRND 08-07-2025
- ALKS 07-23-2025
- Dividend Yield
- GRND N/A
- ALKS N/A
- EPS Growth
- GRND N/A
- ALKS N/A
- EPS
- GRND N/A
- ALKS 2.09
- Revenue
- GRND $363,229,000.00
- ALKS $1,513,770,000.00
- Revenue This Year
- GRND $28.97
- ALKS N/A
- Revenue Next Year
- GRND $21.80
- ALKS $4.18
- P/E Ratio
- GRND N/A
- ALKS $14.15
- Revenue Growth
- GRND 30.08
- ALKS N/A
- 52 Week Low
- GRND $9.14
- ALKS $22.90
- 52 Week High
- GRND $25.13
- ALKS $36.45
- Technical
- Relative Strength Index (RSI)
- GRND 48.63
- ALKS 42.92
- Support Level
- GRND $22.77
- ALKS $30.82
- Resistance Level
- GRND $23.75
- ALKS $32.35
- Average True Range (ATR)
- GRND 0.80
- ALKS 0.79
- MACD
- GRND -0.25
- ALKS -0.09
- Stochastic Oscillator
- GRND 17.90
- ALKS 17.11
About GRND Grindr Inc.
Grindr Inc is a social networking app for gay, bi, trans, and queer people. It is a social network that brings together gay and bisexual men who want to meet other men close to them in a completely discreet and anonymous way, without having to give any personal information or having to fill out a profile with confidential information in order to register.
About ALKS Alkermes plc
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.